SCHEMBL7993363

SCHEMBL7993363

COc1cccc(Nc2ccccc2)c1[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
MAPK1 P28482 5/20 0.54
L3MBTL1 Q9Y468 5/20 0.54
TDP1 Q9NUW8 3/20 0.54
CASP7 P55210 1/20 0.54
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
GAA P10253 2/20 0.51
MAPT P10636 7/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
PKM P14618 1/20 0.47
RECQL P46063 1/20 0.47
DUSP3 P51452 1/20 0.47
PTPN5 P54829 1/20 0.47
PTPN11 Q06124 1/20 0.47
HPGD P15428 2/20 0.45
LMNA P02545 2/20 0.45
POLB P06746 1/20 0.45
ALOX12 P18054 1/20 0.45
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16174932 0.85 TDP1 (0.67) ALDH1A1MAPK1L3MBTL1TDP1CASP7
SCHEMBL7987510 0.84 ALDH1A1 (0.46) ALDH1A1MAPK1L3MBTL1TDP1CASP7
SCHEMBL11900980 0.81 TDP1 (0.58) ALDH1A1MAPK1L3MBTL1TDP1CASP7
SCHEMBL194254 0.80 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1TDP1MEN1
SCHEMBL31040071 0.80 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1TDP1MEN1
SCHEMBL3205552 0.79 TDP1 (0.74) ALDH1A1MAPK1L3MBTL1TDP1CASP7
SCHEMBL2220068 0.78 MEN1 (0.52) ALDH1A1MAPK1L3MBTL1TDP1MEN1
SCHEMBL2220075 0.78 MEN1 (0.52) ALDH1A1MAPK1L3MBTL1TDP1MEN1
SCHEMBL3397565 0.78 MAPT (0.64) ALDH1A1MAPK1L3MBTL1TDP1MEN1
SCHEMBL16174884 0.78 MAPT (0.54) ALDH1A1MAPK1L3MBTL1TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218388-B1 THERAPY OF PROTEIN TYROSINE KINASE MEDIATED CANCER, ATHEROSCLEROSIS, RESTENOSIS, AND PSORIASIS BY ADMINISTERING BENZIMIDAZOLE DERIVATIVE WARNER-LAMBERT COMPANY 2001-04-17 US disclosed